Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiwan to boost biotech R&D and product lines

This article was originally published in Clinica

Executive Summary

Taiwan is to boost its biotechnology translational research with greater investment and infrastructure development. Taiwan's deputy health minister Dr Yen-jen Sung, made the commitment at the APEC Biotechnology Conference in Taipei last month, according to the Taipei Times. The move is to safeguard the region against the potential risks of global epidemics, such as the SARS outbreak in 2003. The first priority would be to attract more researchers and develop research infrastructure, said Mr Sung, followed by the promotion of tech transfer, and the commercialisation of newly-developed products. He said that the government would be financing research in the field.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel